Compare PTRN & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTRN | ICUI |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | United States | United States |
| Employees | 2300 | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 3.6B |
| IPO Year | N/A | 1995 |
| Metric | PTRN | ICUI |
|---|---|---|
| Price | $23.29 | $161.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $19.56 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 2.2M | 242.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | N/A | ★ 1.20 |
| Revenue | N/A | ★ $2,231,262,000.00 |
| Revenue This Year | $27.89 | N/A |
| Revenue Next Year | $22.19 | $4.46 |
| P/E Ratio | ★ N/A | $131.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.19 | $107.02 |
| 52 Week High | $29.80 | $162.85 |
| Indicator | PTRN | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 60.81 |
| Support Level | $10.48 | $139.88 |
| Resistance Level | $29.80 | $161.30 |
| Average True Range (ATR) | 1.53 | 4.72 |
| MACD | -0.96 | -0.52 |
| Stochastic Oscillator | 20.52 | 83.35 |
Pattern Group Inc is an e-commerce accelerator that uses its technology platform, data science, and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics, and customer service. Brand partners that contract with the Company operate in various industries, including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors, and consumer electronics. The Company mainly derives its revenue in the United States by selling products to customers via online marketplaces. The company genrates majority of revenue from the US.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.